PRODUCT Properties
| Melting point: | 123 °C | 
                                    
| Boiling point: | 377.3±17.0 °C(Predicted) | 
                                    
| Density | 1.394±0.06 g/cm3(Predicted) | 
                                    
| storage temp. | 2-8°C | 
                                    
| solubility | soluble in Methanol | 
                                    
| form | powder to crystal | 
                                    
| pka | 3.60±0.30(Predicted) | 
                                    
| color | White to Light yellow to Light orange | 
                                    
| InChI | InChI=1S/C9H7NO3/c11-9(12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H,11,12) | 
                                    
| InChIKey | BVSIAYQIMUUCRW-UHFFFAOYSA-N | 
                                    
| SMILES | O1C2=C(C=CC=C2)C(CC(O)=O)=N1 | 
                                    
| CAS DataBase Reference | 4865-84-3(CAS DataBase Reference) | 
                                    
Description and Uses
1,??2-??Benzisoxazol-??3-??ylacetic Acid-13C2 is the labeled analogue of 1,??2-??Benzisoxazol-??3-??ylacetic Acid. 1,??2-??Benzisoxazol-??3-??ylacetic Acid-13C2 is an intermediate in the synthesis of Zonisamide-13C2-15N (Z700003), the labeled analogue of Zonisamide (Z700000), a sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for potential therapeutic use as an antiepileptic drug. Anticonvulsant.




![BENZO[D]ISOXAZOL-3-YL-METHANESULFONYL CHLORIDE](https://img.chemicalbook.com/CAS/GIF/73101-65-2.gif)


